Dr. Sidhu joins Treadwell with 15 years of experience in hematologic and solid tumor oncology research and development, according to a Feb. 3 release. He most recently served as chief medical officer of Brooklyn ImmunoTherapeutics, now known as Eterna.
Dr. Sidhu previously served as president and chief medical officer of Roivant Sciences, chief medical officer of Cell Design Labs and executive medical director of hematology/oncology therapeutics for Amgen.
He is also a fellow of the Royal College of Physicians and Surgeons of Canada, where he received his medical training.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
